Camelia Merati, DO
Hospitalist · Kalamazoo, MINPI 1467474312
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $203 and has fallen 60.9% since, to $79 in 2025. Among hospitalist clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 57 payments — averaging $15.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$173
- Johnson & Johnson$155
- Pfizer$109
- Novartis$66
- Novo Nordisk$56
- E.r. Squibb & Sons, L.L.C.$50
- plus $292 from 11 others
What the payments were for
- Food & beverage$900100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 13 | $173 |
| Johnson & Johnson | 8 | $155 |
| Pfizer | 7 | $109 |
| Novartis | 4 | $66 |
| Novo Nordisk | 3 | $56 |
| E.r. Squibb & Sons, L.L.C. | 4 | $50 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $47 |
| Melinta Therapeutics, LLC | 2 | $37 |
| Boehringer Ingelheim | 2 | $34 |
| Boston Scientific | 2 | $31 |
| GSK | 2 | $29 |
| AbbVie(2 entities) | 2 | $26 |
| Viatris Specialty LLC | 1 | $23 |
| Neurelis, Inc. | 1 | $20 |
| Vyera Pharmaceuticals, LLC | 1 | $18 |
| Gilead | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $13 |
How this compares
$900 in reported general payments places this provider in the 90th percentile of 342 hospitalist providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naltrexone Hcl | 11 | $600 |
| Cefpodoxime Proxetil | 15 | $501 |
| Omeprazole | 15 | $387 |
| Escitalopram Oxalate | 20 | $372 |
| Levothyroxine Sodium | 30 | $285 |
| Atorvastatin Calcium | 27 | $230 |
| Oxycodone Hcl | 11 | $109 |
| Metformin Hcl | 13 | $96 |
| Amlodipine Besylate | 13 | $77 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Kalamazoo
- Tamim SalmanKalamazoo$2K
- Lukasz NiecKalamazoo$2K
- Shaza Zayzafoon-MosierKalamazoo$698
- Xiaorong YanKalamazoo$604
- James MackayKalamazoo$600
- Scott KaatzDetroit$146K
- Zakhria BelasherWarren$31K
- Johnathon MarkusClinton Twp$17K
- Neetu TalrejaDetroit$16K
- Cecilia NguyenRoyal Oak$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.